Search Results 391-400 of 17424 for bisphosphonates side effects

1. Clinical trials - Oncology (Medical)

   A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...

2. Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. ... The purpose of this study is to estimate the rate of sustained MRD negativity (MRD negative ... * NOTE: ...

3. Osteoporosis - Doctors and departments - Mayo Clinic

   Fractures associated with this bone-weakening condition can be life altering. Good nutrition, regular exercise and medicines can help.

4. A Study of Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for Relapsed Multiple Myeloma - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. ... Negative pregnancy test done ≤7 days prior to ... Note: Bisphosphonates are supportive care rather ...

5. A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower130) - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current ...

6. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. ... HER2 is negative if a single test (or all tests) ... Concurrent bisphosphonate therapy is allowed.

7. Fibromuscular dysplasia - Symptoms and causes - Mayo Clinic

   Narrowed arteries can reduce blood flow and affect how body organs work. Fibromuscular dysplasia is most often seen in the arteries leading to the kidneys and ...

8. Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor - Mayo Clinic

   ... side effects, optimal dosages and risks/benefits. In the later phase (phase ... Participants receiving bisphosphonate or denosumab therapy must have ...

9. Nilotinib and Combination Chemotherapy in Treating Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia - Mayo Clinic

   In this study researchers want to find out more about the side effects of a new drug for Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia ...

10. Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib - Mayo Clinic

    ... side effects, optimal dosages and risks/benefits. ... Negative hepatitis B test (defined by a negative ... NOTE: Bisphosphonates are considered to be ...